Plus, Goldman Sachs said fears that a delayed U.S. election result could upend the stock market are overblown, Novavax entered a late stage trial for its coronavirus vaccine candidate, and Amazon announced two new Fire TV sticks.
Read MorePlus, President Trump refused to commit to a peaceful transition of power should he lose the November election, last week’s initial jobless claims were higher than expected, and United Airlines is about to start offering rapid coronavirus tests to some fliers to Hawaii.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company’s lead product […]
Read MorePlus, Johnson & Johnson started its phase three trial for its possible coronavirus vaccine, Nike shares are up after its earnings report, and Tesla shares are down after its disappointing Battery Day event.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in […]
Read MorePlus, Atlanta Fed President Bostic urged Congress to pass additional fiscal support for the U.S. economy, Herman Miller shares surged after the company’s blowout earnings report, and Beyond Meat shares are down following a downgrade.
Read MoreBuy Price: $11.00 or better Sell Price: TradersPro Sell Signal INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient’s innate immune system to treat cancer Alzheimer’s disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies and solid tumors. Its development programs include INKmune
Read MorePlus, jobless claims were lower than expected for last week though recovery in the labor market appears to be slowing, there’s a glimmer of hope on the stimulus front, and Moderna said it should have data for its late-stage coronavirus vaccine trial in November.
Read MorePlus, weekly jobless claims were higher than expected, AstraZeneca said it still expects to know whether its coronavirus vaccine will be safe and effective before the end of this year, and LVMH is suing Tiffany.
Read MorePlus, LVMH is scrapping its bid for Tiffany, Lululemon delivered an earnings beat, and Walmart is testing drone delivery for grocery items.
Read MorePlus, ADP said private payrolls grew by just 428,000 in August, and Macy’s shares are up even after posting a loss as online sales jump 53% in its most recent quarter.
Read MorePlus, Tesla said it plans to sell up to $5 billion in new stock, Walmart said it will launch its Walmart+ subscription service on September 15, and Apple is expected to announced its new iPhones in October.
Read MoreOne stock looks primed to see the biggest benefit from being added to the Dow Jones Industrial Average this week.
Read MorePlus, Moderna said its coronavirus vaccine candidate showed a promising immune response in older patients in an early trial, Kansas City Fed President Esther George warned of a double-dip recession, and McDonald’s has reportedly expanded the scope of its investigation against former CEO Easterbrook.
Read MoreI seem to be noticing a new trend, not just among average consumers and investors, but even among people that I think should be hard-wired to know better, and that’s a desire to just write off 2020 and hit the reset switch. A lot of the commentary and debate among talking heads and market news […]
Read More